The results showed that ITGA1/ITGA2 expression levels were dramatically decreased in PCa patient tumors with ITGA1/ITGA2 copy number loss/deletion (loss/del) in two independent clinical PCa cohorts (Figure 1d,e; Figure S1b,c, Supporting Information). This evidence concerns the gene ITGA1 and posterior cortical atrophy.